Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
42.87%
operating margin TTM
34.19%
revenue TTM
271.96 Million
revenue per share TTM
1.14$
valuation ratios | |
|---|---|
| pe ratio | 19.83 |
| peg ratio | 0.20 |
| price to book ratio | 9.63 |
| price to sales ratio | 8.48 |
| enterprise value multiple | 23.95 |
| price fair value | 9.63 |
profitability ratios | |
|---|---|
| gross profit margin | 54.71% |
| operating profit margin | 34.19% |
| pretax profit margin | 31.88% |
| net profit margin | 42.87% |
| return on assets | 36.83% |
| return on equity | 53.98% |
| return on capital employed | 32.61% |
liquidity ratios | |
|---|---|
| current ratio | 7.13 |
| quick ratio | 3.65 |
| cash ratio | 1.09 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 324.41 |
| operating cycle | 427.26 |
| days of payables outstanding | 39.62 |
| cash conversion cycle | 387.64 |
| receivables turnover | 3.55 |
| payables turnover | 9.21 |
| inventory turnover | 1.13 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.15 |
| debt equity ratio | 0.19 |
| long term debt to capitalization | 0.14 |
| total debt to capitalization | 0.16 |
| interest coverage | 19.97 |
| cash flow to debt ratio | 0.78 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.17 |
| cash per share | 0.26 |
| operating cash flow per share | 0.27 |
| free cash flow operating cash flow ratio | 0.63 |
| cash flow coverage ratios | 0.78 |
| short term coverage ratios | 17.84 |
| capital expenditure coverage ratio | 2.68 |
Frequently Asked Questions
When was the last time ADMA Biologics, Inc. (NASDAQ:ADMA) reported earnings?
ADMA Biologics, Inc. (ADMA) published its most recent earnings results on 05-11-2025.
What is ADMA Biologics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ADMA Biologics, Inc. (NASDAQ:ADMA)'s trailing twelve months ROE is 53.98%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ADMA Biologics, Inc. (ADMA) currently has a ROA of 36.83%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ADMA's net profit margin stand at?
ADMA reported a profit margin of 42.87% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ADMA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 7.13 in the most recent quarter. The quick ratio stood at 3.65, with a Debt/Eq ratio of 0.19.